Forel, Jean-Marie

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

Papazian, L., Forel, J.-M., Gacouin, A., Penot-Ragon, C., Perrin, G., Loundou, A., Jaber, S., Arnal, J.-M., Perez, D., Seghboyan, J.-M., et al. (2010) · New England Journal of Medicine

Respiratory Support and MechanismsIntensive Care Unit Cognitive Disorders

Cited by 2,432

Initiation strategies for renal-replacement therapy in the intensive care unit.

Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine

Acute Kidney Injury ResearchRespiratory Support and Mechanisms

Cited by 1,243

Formal guidelines: Management of acute respiratory distress syndrome.

Papazian, L., Aubron, C., Brochard, L., Chiche, J.-D., Combes, A., Dreyfuss, D., Forel, J.-M., Guérin, C., Jaber, S., Mekontso-Dessap, A., et al. (2019) · Annals of Intensive Care

Respiratory Support and MechanismsNeonatal Respiratory Health Research

Cited by 761

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Carvelli, J., Demaria, O., Vély, F., Batista, L., Chouaki Benmansour, N., Fares, J., Carpentier, S., Thibult, M.-L., Morel, A., Remark, R., et al. (2020) · Nature

COVID-19 Clinical Research StudiesComplement system in diseases

Cited by 526

Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome.

Forel, J.-M., Roch, A., Marin, V., Michelet, P., Demory, D., Blache, J.-L., Perrin, G., Gainnier, M., Bongrand, P., & Papazian, L. (2006) · Critical Care Medicine

Respiratory Support and MechanismsIntensive Care Unit Cognitive Disorders

Cited by 400

Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome.

Gainnier, M., Roch, A., Forel, J.-M., Thirion, X., Arnal, J.-M., Donati, S., & Papazian, L. (2004) · Critical Care Medicine

Respiratory Support and MechanismsIntensive Care Unit Cognitive Disorders

Cited by 349

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 192